Randomized, Open-label, Multicenter Study of Icotinib as Adjuvant Therapy in Treating Stage II-IIIA Non-small-cell Lung Cancer Patients With Positive EGFR ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2013-2017

ABSTRACT

This study is designed to evaluate the efficacy of icotinib as adjuvant therapy in treating such patients. The primary endpoint is to compare the recurrence-free survival after 1-year or 2-year treatment with icotinib. Detailed Description Adjuvant therapy has been proved effective in treating stage II-IIIA non-small-cell lung cancer. However, few data on the treating time of adjuvant therapy is available. Here we conduct a randomized, prospective study to compare the recurrence-free survival after 1-year or 2-year treatment with icotinib in EGFR-mutated non-small cell lung cancer patients. More... »

URL

https://clinicaltrials.gov/show/NCT01929200

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This study is designed to evaluate the efficacy of icotinib as adjuvant therapy in treating such patients. The primary endpoint is to compare the recurrence-free survival after 1-year or 2-year treatment with icotinib.\n\nDetailed Description\nAdjuvant therapy has been proved effective in treating stage II-IIIA non-small-cell lung cancer. However, few data on the treating time of adjuvant therapy is available. Here we conduct a randomized, prospective study to compare the recurrence-free survival after 1-year or 2-year treatment with icotinib in EGFR-mutated non-small cell lung cancer patients.", 
    "endDate": "2017-08-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01929200", 
    "keywords": [
      "label", 
      "multicenter study", 
      "non-small cell lung cancer patient", 
      "EGFR mutation", 
      "efficacy", 
      "adjuvant therapy", 
      "patient", 
      "primary endpoint", 
      "recurrence-free survival", 
      "adjuvant", 
      "therapy", 
      "non small cell lung cancer", 
      "prospective study"
    ], 
    "name": "Randomized, Open-label, Multicenter Study of Icotinib as Adjuvant Therapy in Treating Stage II-IIIA Non-small-cell Lung Cancer Patients With Positive EGFR Mutation", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01929200"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00015.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.412474.0", 
        "type": "Organization"
      }
    ], 
    "startDate": "2013-08-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/1477-7819-11-96", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021210817", 
          "https://doi.org/10.1186/1477-7819-11-96"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01929200"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01929200'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01929200'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01929200'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01929200'


 

This table displays all metadata directly associated to this object as RDF triples.

36 TRIPLES      16 PREDICATES      29 URIs      22 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01929200 schema:about anzsrc-for:3142
2 schema:description This study is designed to evaluate the efficacy of icotinib as adjuvant therapy in treating such patients. The primary endpoint is to compare the recurrence-free survival after 1-year or 2-year treatment with icotinib. Detailed Description Adjuvant therapy has been proved effective in treating stage II-IIIA non-small-cell lung cancer. However, few data on the treating time of adjuvant therapy is available. Here we conduct a randomized, prospective study to compare the recurrence-free survival after 1-year or 2-year treatment with icotinib in EGFR-mutated non-small cell lung cancer patients.
3 schema:endDate 2017-08-01T00:00:00Z
4 schema:keywords EGFR mutation
5 adjuvant
6 adjuvant therapy
7 efficacy
8 label
9 multicenter study
10 non small cell lung cancer
11 non-small cell lung cancer patient
12 patient
13 primary endpoint
14 prospective study
15 recurrence-free survival
16 therapy
17 schema:name Randomized, Open-label, Multicenter Study of Icotinib as Adjuvant Therapy in Treating Stage II-IIIA Non-small-cell Lung Cancer Patients With Positive EGFR Mutation
18 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01929200
19 schema:sdDatePublished 2019-03-07T15:25
20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
21 schema:sdPublisher Nbe70662bd7c548a597e79655e6070053
22 schema:sponsor https://www.grid.ac/institutes/grid.412474.0
23 schema:startDate 2013-08-01T00:00:00Z
24 schema:subjectOf sg:pub.10.1186/1477-7819-11-96
25 schema:url https://clinicaltrials.gov/show/NCT01929200
26 sgo:license sg:explorer/license/
27 sgo:sdDataset clinical_trials
28 rdf:type schema:MedicalStudy
29 Nbe70662bd7c548a597e79655e6070053 schema:name Springer Nature - SN SciGraph project
30 rdf:type schema:Organization
31 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
32 rdf:type schema:DefinedTerm
33 sg:pub.10.1186/1477-7819-11-96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021210817
34 https://doi.org/10.1186/1477-7819-11-96
35 rdf:type schema:CreativeWork
36 https://www.grid.ac/institutes/grid.412474.0 schema:Organization
 




Preview window. Press ESC to close (or click here)


...